A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors

The purpose of this study is to find out whether the study drug, LY4101174, is safe, tolerable and effective in participants with advanced, or metastatic solid tumors.

Enter your city or zip code to find the nearest site

Trial Summary

Age Range
≥18 years
Conditions the trial is for
Solid tumors
What the trial is testing?
Could I receive a Placebo?
Enrollment Goal
Trial Dates
Mar 5, 2024 - Mar 2027
How long will I be in the trial?
The study will last up to approximately 4 years
Trial Phase

Key Requirements

Clinical trials have inclusion and exclusion requirements to determine which individuals qualify for participation. Listed below are key requirements for this clinical trial, but there may be additional requirements to qualify.

Participants Must:

  • Have one of the following solid tumor cancers:

    urothelial cancer, triple negative breast cancer, non-small cell lung cancer, esophageal cancer, pancreatic cancer, ovarian cancer, cervical cancer (squamous cell cancer), head and neck squamous cell cancer or prostate cancer

  • Have stopped all cancer treatment and have recovered from the major side effects

  • Have blood test results that show that organs are working adequately

Participants Must Not:

  • Have cancer that spread to the brain and is causing symptoms

  • Have uncontrolled increase in serum calcium levels

  • Have serious disorder of the eye

  • Have serious heart condition, or lung disease

  • Have serious skin toxicity when receiving enfortumab vedotin

  • Be pregnant, breastfeeding or plan to breastfeed during study or within 30 days of last dose of study intervention

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.

Clinical Trial Resources

Cancer Research

Lilly has been involved in cancer research for more than fifty years, working to improve the lives of people living with cancer. Learn more about cancer research at Lilly and how you can make an impact.

Learn More

Learn About Our Early and Metastatic Breast Cancer Research

With the help of research study participants, we are learning potential new ways to improve Breast Cancer health outcomes.

Learn More

Prostate Cancer Research

By volunteering to take part in Prostate cancer clinical trials, you may be able to play an important role in the research and development of potential new treatments and medicines. We understand that when you or a loved one take part in a clinical trial, it is a big decision. It is important for you to understand why the research is being carried out and what taking part will mean for you. Learn more about Lilly

Prostate Cancer Research

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study. It helps us learn if a new medicine or treatment works and how it works. Clinical trials can also be called clinical research studies. Learn more about clinical research studies and what to expect when taking part in a clinical trial.